Biogen Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Amortized Cost increased by 10.4% to $1.37B in Q1 2026 compared to the prior quarter.
A balanced maturity profile suggests effective asset-liability management, while heavy concentration in specific periods may indicate liquidity or reinvestment risk.
This metric reports the amortized cost of available-for-sale debt securities categorized by specific maturity dates. It...
Standard maturity schedule disclosure required for financial institutions to demonstrate liquidity management.
other_available_for_sale_securities_debt_maturities_sing_cafefc| Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|
| Value | $97.60M | $1.24B | $1.37B |
| QoQ Change | — | >999% | +10.4% |